Pyridone-6-CMP-6-DataSheet-生命科学试剂-MedChemExpress_第1页
Pyridone-6-CMP-6-DataSheet-生命科学试剂-MedChemExpress_第2页
Pyridone-6-CMP-6-DataSheet-生命科学试剂-MedChemExpress_第3页
Pyridone-6-CMP-6-DataSheet-生命科学试剂-MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEPyridone 6Cat. No.: HY-14435CAS No.: 457081-03-7Synonyms: CMP 6; JAK Inhibitor分式: CHFNO分量: 309.34作靶点: JAK作通路: Epigenetics; JAK/STAT Signaling; Stem Cell/Wnt储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解

2、性数据体外实验 DMSO : 100 mg/mL (323.27 mM)H2O : 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (8.08 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% (20% SBE-CD in saline)1/3 Master of Small Molecules 您边的抑制剂师www.MedChemESolubility: 2.5 mg/mL (8.08 mM); Suspended solution; Need ultrasonic3. 请依序添加每种溶剂

3、: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (8.08 mM); Clear solutionBIOLOGICAL ACTIVITY物活性 Pyridone 6种 pan-JAK 抑制剂,有效抑制 JAK 激酶家族,作于 JAK2,TYK2,JAK3 和 JAK1,IC50 分别为 1 nM,1 nM,5 nM 和 15 nM。IC50 & Target JAK2 Tyk2 JAK3 Murine JAK11 nM (IC50) 1 nM (IC50) 5 nM (IC50) 15 nM (IC50)CDK2 cAMP-dependent Csk

4、Hck3.3 M (IC50) kinase 2.1 M (IC50) 7.7 M (IC50)7.1 M (IC50)Fyn T p38 MAPK Mek0.5 M (IC50) 11 M (IC50) 1.78 M (IC50) 0.16 M (IC50)IB Kinase 2 KDR Flt-1 Flt-40.3 M (IC50) 1.4 M (IC50) 1.52 M (IC50) 0.69 M (IC50)FGFR FGFR2 Tek PDGFR1.48 M (IC50) 0.94 M (IC50) 24 M (IC50) 1.49 M (IC50)PKC()1.2 M (IC50)

5、体外研究 Pyridone 6 is tested as an inhibitor of 21 other protein kinases; Pyridone 6 inhibits these kinases with IC50sranging from 130 nM to 10 M. Pyridone 6 inhibits IL2 driven proliferation of CTLL cells with IC50=0.1 Mand IL4 driven proliferation with IC50=0.052 M 1. Pyridone 6 (P6) is shown to inhi

6、bit kinase by interactingwithin the ATP-binding cleft of each JAK. The IC50 of Pyridone 6 is 3 nM for all of these cytokines; this iscomparable to the reported IC50s of Pyridone 6 for JAK2, Tyk2, and JAK3. Pyridone 6 strongly inhibits Th2and modestly inhibits Th1, whereas it enhances Th17 developmen

7、t when present within a certain range ofconcentrations. Pyridone 6 reduces IFN- and IL-13, whereas it enhances IL-17 and IL-22 expression.Pyridone 6 also inhibits both Th1 and Th2 development, whereas it promotes Th17 differentiation from naiveT cells when present within a certain range of concentra

8、tions 2.体内研究 Pyridone 6 (P6) delays the onset and reduced the magnitude of skin disease in an AD-like skin-diseasemodel of NC/Nga mice. P6-nano strongly ameliorates atopic dermatitis (AD) in NC/Nga mice, exerting aneffect comparable to that of betamethasone ointment, a commonly used drug, which also

9、 tested as a positivecontrol. In contrast, empty polylactic acid with glycolic acid (PLGA) nanoparticles (C-nano) seemed to haveno effect 2.2/3 Master of Small Molecules 您边的抑制剂师www.MedChemEPROTOCOLCell Assay 2 Naive CD4+ T cells are treated with various concentrations of Pyridone 6 (10 and 30 nM) in

10、 RPMI 1640medium 1 h before the appropriate cytokines are added to create each Th-differentiating condition.Immunoblotting is performed using antiphospho-STAT protein Abs or anti-total STAT protein Abs 2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.A

11、nimal Mice 2Administration 2 NC/Nga mice are used at the age of 10-15 wk. To assess the effect of Pyridone 6 treatment on ADsymptoms, nanoparticles containing Pyridone 6 (2 mg/body) or empty nanoparticles as a negative control (C-nano) are dissolved in 0.1 mL saline and administered s.c. 1 d after D

12、fb ointment application; this treatmentis repeated twice a week. To assess the effects of recombinant murine IL-17 and IL-22, these cytokines (50 g/kg) or 100 L PBS is administered for the same duration as the nanoparticles. Twenty milligrams of 0.064%betamethasone ointment are applied to the dorsal

13、 lesion of mice once a week 2.MCE has not independently confirmed the accuracy of these methods. They are for reference only.户使本产品发表的科研献 Leukemia. 2012 Oct;26(10):2233-44. Patent. US20160368910A1. Patent. US20140309249A1. Chem Biol. 2012 Jan 27;19(1):140-54.See more customer validations on HYPERLINK

14、 / www.MedChemEREFERENCES1. Thompson JE, et al. Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg Med ChemLett. 2002 Apr 22;12(8):1219-23.2. Nakagawa R, et al. Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 andenhancement of Th17. J Immunol. 2011 Nov 1;187

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论